About this trial
Appropriate antimicrobial therapy is essential to ensuring positive patient outcomes. Inappropriate or suboptimal utilization of antibiotics can lead to increased length of stay, multidrug-resistant infections, and mortality. Critically ill intensive care patients are at risk of antibiotic failure and secondary infections associated with incorrect antibiotic use. Initiating effective therapy for infections based upon patients' risk factors, collection of appropriate cultures, daily evaluation of clinical status, and laboratory data, including antibiotic time outs, and shortened duration of therapy are ways to improve patients outcomes. Antimicrobial stewardship teams can assist ICU providers in managing and implementing these tactics. ICUs would benefit from employing empiric guidelines for antibiotic use, collecting appropriate specimens and implementing molecular diagnostics, optimizing the dosing of antibiotics, and reducing the duration of total therapy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients admitted to the ICU for more than 48 hour
Disqualifiers
Patients admitted to ICU less than 48 hours
Trial population
ICU patient
Trial design
Cohort
Prospective
Treatments tested in this trial
antimicrobial therapy
Other interventionantimicrobial therapy
Treatment groups
Trial outcomes
Primary outcomes
survival rate
the survival rate of children in 21 days after ICU admission
Secondary outcomes
the length of ICU stay time
the length of ICU stay time
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: